Belinostat and its Impurities
Belinostat trade name Beleodaq, previously known as PXD101. It is a histone deacetylase (HDAC) inhibitor used for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma. Reference standards of Belinostat API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
